MSME (Udyam registered) Ministry of MSME
- Category
- Small (2023-24)
- Udyam number
- UDYAM-KL-13-0004416
Elma Pharmaceuticals Private Limited - pharma in Thrissur, Kerala, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹14.46 Cr
▲ 1% YoY
Net loss · FY 2025
₹2.04 Lakh
Net margin -0.1%
EBITDA · FY 2025
₹1.09 Cr
EBITDA margin 7.5%
Authorised capital
₹25 Lakh
Registered with MCA
Paid-up capital
₹25 Lakh
Issued & subscribed
Open charges
₹2.83 Cr
Satisfied ₹2.78 Cr
Company age
22 yrs
Est. 2004
Employees · EPFO
29
Provident fund records
About Elma Pharmaceuticals Private Limited
Data last updated:
Elma Pharmaceuticals Private Limited is a private limited company based in Thrissur, Kerala, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 28 October 2004 and has been in existence for over 22 years.
The company is registered with the Registrar of Companies (ROC), Ernakulam, under CIN U24232KL2004PTC017560. Its GSTIN is 32AABCE6221B1ZH (Kerala).
The company has an authorised share capital of ₹25 Lakh and a paid-up capital of ₹25 Lakh. It is led by directors including Pallipuram Village Narayanan Sahasranaman (Managing Director) and Panadan Poulose Shaju.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Tc – 2/587/1 Laloor Road Elthuruth Po, Thrissur, Kerala, India – 680611.
As per the financials filed for FY 2025, the company reported a revenue of ₹14.46 Cr, a growth of 1% compared to the previous year. For the same year it recorded a net loss of ₹2.04 Lakh (net margin -0.1%) and EBITDA of ₹1.09 Cr (EBITDA margin 7.5%). Revenue has grown at a compounded annual rate (CAGR) of 11% over three years and 10% over five years.
The company has about 29 employees on its provident fund (EPFO) records. Its group structure includes 2 subsidiaries.
As per MCA filings, the company has open charges of ₹2.83 Cr and satisfied charges of ₹2.78 Cr on record.
Elma Pharmaceuticals Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-KL-13-0004416). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website elmapharma.com.
Company Details of Elma Pharmaceuticals Private Limited
CIN U24232KL2004PTC017560
Registration Number 017560
Incorporation Date 28 October 2004
ROC Ernakulam
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-KL-13-0004416
Key People
Pallipuram Village Narayanan Sahasranaman Managing Director Panadan Poulose Shaju Director Sukumar Amrutha Director Recognitions & Rankings of Elma Pharmaceuticals
Contact Details
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered AddressTc – 2/587/1 Laloor Road Elthuruth Po, Thrissur, Kerala, India – 680611
- IndustryPharma, Drug Formulation & Development
Comprehensive company report
Elma Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business Activity of Elma Pharmaceuticals Private Limited
The main business activity of Elma Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Premium access
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Elma Pharmaceuticals Private Limited FY 2025 filings available
Elma Pharmaceuticals Private Limited reported revenue of ₹14.46 Cr (up 1% YoY) for FY 2025.
Revenue · FY 2025
₹14.46 Cr ▲ 1%
Net loss · FY 2025
₹2.04 Lakh margin -0.1%
EBITDA · FY 2025
₹1.09 Cr margin 7.5%
Compounded Annual Growth Rate (CAGR) of Elma Pharmaceuticals Private Limited
Revenue CAGR growth
1 year
▲ 1%
3 years · compounded
▲ 11%
5 years · compounded
▲ 10%
EBITDA CAGR growth
1 year
▼ 18%
3 years · compounded
▼ 5%
5 years · compounded
▲ 7%
Revenue has grown at a compounded annual rate (CAGR) of 10% over five years, including 1% growth in the latest year. EBITDA fell 18% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Elma Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹1.09 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹2.04 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Elma Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 7.5% | •••• | •••• | •••• | •••• |
| Net Profit Margin | -0.1% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Elma Pharmaceuticals are in the company report.
Premium access
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Elma Pharmaceuticals Private Limited
Elma Pharmaceuticals has 5 current directors and 6 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Panadan Poulose Shaju Also directs: Munus Pharmaceuticals Private Limited | Director | 26 Oct 2007 | 18 Years 11 Months | Current |
| Sukumar Amrutha Also directs: Munus Pharmaceuticals Private Limited | Director | 26 Oct 2007 | 18 Years 11 Months | Current |
| Sajimon Abraham Also directs: Munus Pharmaceuticals Private Limited | Director | 01 Nov 2008 | 17 Years 11 Months | Current |
| Nadancheri Padikkal Padath Ajith Also directs: Munus Pharmaceuticals Private Limited | Director | 29 Oct 2004 | 21 Years 11 Months | Current |
| Pallipuram Village Narayanan Sahasranaman Also directs: Munus Pharmaceuticals Private Limited | Managing Director | 20 Jul 2006 | 20 Years 3 Months | Current |
Peer Comparison of Elma Pharmaceuticals Private Limited
Elma Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Roerich Health Care Private Limited | ₹14.59 Cr (FY 2024) | •••• | •••• | -49.0% | •••• | Hyderabad, Telangana, India |
| Aditi Pharmaceuticals Pvt Ltd | ₹14.54 Cr (FY 2025) | •••• | •••• | -8.0% | •••• | Solapur, Maharashtra, India |
| Adore Pharmaceuticals Pvt Ltd | ₹14.54 Cr (FY 2024) | •••• | •••• | 3.0% | •••• | Vasai, Maharashtra, India |
| Lactonova Nutripharm Private Limited | ₹14.52 Cr (FY 2025) | •••• | •••• | 28.0% | •••• | Hyderabad, Telangana, India |
| Ryesino Pharmaceuticals Private Limited | ₹14.49 Cr (FY 2024) | •••• | •••• | 11.0% | •••• | Uttar Pradesh, India |
| Elma Pharmaceuticals Private Limited this company | ₹14.46 Cr (FY 2025) | •••• | •••• | 1.0% | •••• | Thrissur, Kerala, India |
| Iza Pharmaceuticals Private Limited | ₹14.44 Cr (FY 2025) | •••• | •••• | 21.0% | •••• | Kozhikode, Kerala, India |
| Katama Biomed Private Limited | ₹14.41 Cr (FY 2024) | •••• | •••• | -27.0% | •••• | Chennai, Tamil Nadu, India |
| Prabhava Organics Private Limited | ₹14.39 Cr (FY 2025) | •••• | •••• | 42.0% | •••• | Hyderabad, Telangana, India |
| Genmedic Healthcare Private Limited | ₹14.35 Cr (FY 2024) | •••• | •••• | -15.0% | •••• | Hyderabad Ranga Reddy, Telangana, India |
| Kola Pharma Private Limited | ₹14.33 Cr (FY 2022) | •••• | •••• | 50.0% | •••• | Hyderabad, Telangana, India |
Peers are the five companies nearest above and the five nearest below Elma Pharmaceuticals by revenue in the Pharma industry (Formulations, Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Elma Pharmaceuticals Private Limited
Elma Pharmaceuticals Private Limited is audited by VASU & SIVARAM for the financial year 2020.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| VASU & SIVARAM | Locked | Locked | Locked |
Premium access
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Elma Pharmaceuticals Private Limited
Premium access
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Elma Pharmaceuticals Private Limited
Open charges
₹2.83 Cr
Satisfied charges
₹2.78 Cr
Breakdown by lending institutions
Latest charge details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 Dec 2023 | Others | ₹2.33 Cr | Open |
| 27 Aug 2020 | Others | ₹50 Lakh | Open |
| 11 Feb 2021 | Others | ₹2 Cr | Satisfied |
| 06 Dec 2014 | The South Indian Bank Limited | ₹28 Lakh | Satisfied |
| 05 Dec 2014 | The South Indian Bank Limited | ₹42 Lakh | Satisfied |
Total charge records: 6 View all charges
Employees and EPFO Compliance at Elma Pharmaceuticals Private Limited
Elma Pharmaceuticals Private Limited has a workforce of 29 employees as of Apr 05, 2024.
Employee count
29
Active EPFO establishments
1
Premium access
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Group Structure of Elma Pharmaceuticals Private Limited
Elma Pharmaceuticals has 2 subsidiary companies. This group structure data is as of FY 2020. The table lists each entity with its relationship and holding.
2
Subsidiary companies
Key Subsidiaries
| Company Name | CIN | Shares Held |
|---|---|---|
| Elma Bio Care Private Limited | U24290KL2020PTC061105 | Locked |
| Munus Pharmaceuticals Private Limited | U24304KL2016PTC047341 | Locked |
Showing major subsidiaries. Total: 2.
Recent Activity on Elma Pharmaceuticals Private Limited
Elma Pharmaceuticals Private Limited has 11 board changes on record since 2004: 5 appointments and 6 cessations. The latest: Panadan Poulose Shaju ceased to be Managing Director on 29 Sep 2022.
AGM
Elma Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Elma Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ernakulam.
Charges
A charge with Others of Rs. 50.00 Lakh registered on 27 Aug 2020 with Charge ID 100366593 was modified on 25 Mar 2025.
Charges
A charge registered on 26 May 2005 via Charge ID 90020708 with South Indian Bank Limited was fully satisfied on 11 Jul 2024.
Charges
A charge registered on 06 Dec 2014 via Charge ID 10539385 with The South Indian Bank Limited was fully satisfied on 21 Jun 2024.
Charges
A charge registered on 05 Dec 2014 via Charge ID 10539387 with The South Indian Bank Limited was fully satisfied on 21 Jun 2024.
Charges
A charge registered on 11 Feb 2021 via Charge ID 100418301 with Others was fully satisfied on 14 Jun 2024.
Charges
A charge with Others amounted to Rs. 232.55 Lakh with Charge ID 100844442 was registered on 30 Dec 2023.
Ceased
Panadan Poulose Shaju ceased to be Managing Director.
Charges
A charge with Others amounted to Rs. 200.00 Lakh with Charge ID 100418301 was registered on 11 Feb 2021.
Charges
A charge with Others amounted to Rs. 50.00 Lakh with Charge ID 100366593 was registered on 27 Aug 2020.
Ceased
Sukumar Amrutha ceased to be Managing Director.
13 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Elma Pharmaceuticals Private Limited
Premium access
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Elma Pharmaceuticals Private Limited
Premium access
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Elma Pharmaceuticals Private Limited
Premium access
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Elma Pharmaceuticals Private Limited
Elma Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 32AABCE6221B1ZH | Kerala | Active | 01 Jul 2017 |
Premium access
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Elma Pharmaceuticals Private Limited
Premium access
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Elma Pharmaceuticals Private Limited
Elma Pharmaceuticals is an active private limited company based in Thrissur, Kerala, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 28 October 2004 (22+ years old) and is registered under CIN U24232KL2004PTC017560.
Elma Pharmaceuticals reported revenue of ₹14.46 Cr for FY 2025 (up 1% YoY).
Elma Pharmaceuticals has 5 current directors:
- Pallipuram Village Narayanan Sahasranaman - Managing Director
- Panadan Poulose Shaju - Director
- Sukumar Amrutha - Director
- Sajimon Abraham - Director
- Nadancheri Padikkal Padath Ajith - Director
Elma Pharmaceuticals reported a net loss of ₹2.04 Lakh (net margin -0.1%) and EBITDA of ₹1.09 Cr (EBITDA margin 7.5%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Elma Pharmaceuticals is 11% over three years and 10% over five years. In the latest year (FY 2025) revenue rose 1%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Elma Pharmaceuticals is 32AABCE6221B1ZH, registered in Kerala.
The CIN (Corporate Identification Number) of Elma Pharmaceuticals is U24232KL2004PTC017560. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Elma Pharmaceuticals was incorporated on 28 October 2004, making it 22+ years old. It is registered with the Registrar of Companies, Ernakulam.
The peers of Elma Pharmaceuticals by revenue are Roerich Health Care Private Limited, Aditi Pharmaceuticals Pvt Ltd, Adore Pharmaceuticals Pvt Ltd, Lactonova Nutripharm Private Limited, Ryesino Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Formulations, Pharmaceuticals).
Panadan Poulose Shaju ceased to be Managing Director on 29 Sep 2022. Sukumar Amrutha ceased to be Managing Director on 19 Sep 2015. Nadancheri Padikkal Padath Ajith ceased to be Managing Director on 30 Sep 2013. Elma Pharmaceuticals has 11 board changes on record in total.
Yes, Elma Pharmaceuticals is registered as a small enterprise under Udyam registration (number: UDYAM-KL-13-0004416).